Short bowel syndrome and small bowel transplantation

John K. DiBaise

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

PURPOSE OF REVIEW: The purpose of this review is to provide an update of recent advances in the areas of short bowel syndrome (SBS) and small bowel transplantation (SBT). RECENT FINDINGS: Recent reports from two of the largest multicenter randomized, controlled trials in patients with SBS support the safety and efficacy of teduglutide as an aid to parenteral nutrition weaning. In well selected SBS patients, outcomes as diverse as survival, macronutrient absorption and parenteral nutrition weaning are improved after autologous gastrointestinal reconstructive surgery. SBT is no longer considered investigational and given improved outcomes noted in recent reports, indications for transplantation are expanding. Although SBT early survival rates are approaching those of other organ allografts, long-term graft survival remains suboptimal. SUMMARY: Recently available trophic factors hold promise as aids in restoring freedom from parenteral nutrition support; however, their long-term benefits, preferred timing of administration in relation to the onset of SBS, optimal patient selection for use, duration of treatment and cost effectiveness require further study. Despite recent evidence of improved early survival after SBT, more dedicated research is needed to design more effective strategies to better tolerize small bowel grafts, prevent rejection and, ultimately, improve long-term outcomes. Reserved for well selected patients, autologous gastrointestinal reconstruction should be considered complementary and not antagonistic to SBT.

Original languageEnglish (US)
Pages (from-to)128-133
Number of pages6
JournalCurrent Opinion in Gastroenterology
Volume30
Issue number2
DOIs
StatePublished - Mar 2014

Fingerprint

Short Bowel Syndrome
Transplantation
Parenteral Nutrition
Weaning
Reconstructive Surgical Procedures
Survival
Graft Rejection
Graft Survival
Health Care Costs
Patient Selection
Cost-Benefit Analysis
Allografts
Survival Rate
Randomized Controlled Trials
Safety
Research

Keywords

  • Autologous gastrointestinal reconstruction
  • Intestinal adaptation
  • Short bowel syndrome
  • Small bowel transplantation
  • Trophic factor

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Short bowel syndrome and small bowel transplantation. / DiBaise, John K.

In: Current Opinion in Gastroenterology, Vol. 30, No. 2, 03.2014, p. 128-133.

Research output: Contribution to journalArticle

DiBaise, John K. / Short bowel syndrome and small bowel transplantation. In: Current Opinion in Gastroenterology. 2014 ; Vol. 30, No. 2. pp. 128-133.
@article{a2c694902b6f41fda7e3bb8de035343b,
title = "Short bowel syndrome and small bowel transplantation",
abstract = "PURPOSE OF REVIEW: The purpose of this review is to provide an update of recent advances in the areas of short bowel syndrome (SBS) and small bowel transplantation (SBT). RECENT FINDINGS: Recent reports from two of the largest multicenter randomized, controlled trials in patients with SBS support the safety and efficacy of teduglutide as an aid to parenteral nutrition weaning. In well selected SBS patients, outcomes as diverse as survival, macronutrient absorption and parenteral nutrition weaning are improved after autologous gastrointestinal reconstructive surgery. SBT is no longer considered investigational and given improved outcomes noted in recent reports, indications for transplantation are expanding. Although SBT early survival rates are approaching those of other organ allografts, long-term graft survival remains suboptimal. SUMMARY: Recently available trophic factors hold promise as aids in restoring freedom from parenteral nutrition support; however, their long-term benefits, preferred timing of administration in relation to the onset of SBS, optimal patient selection for use, duration of treatment and cost effectiveness require further study. Despite recent evidence of improved early survival after SBT, more dedicated research is needed to design more effective strategies to better tolerize small bowel grafts, prevent rejection and, ultimately, improve long-term outcomes. Reserved for well selected patients, autologous gastrointestinal reconstruction should be considered complementary and not antagonistic to SBT.",
keywords = "Autologous gastrointestinal reconstruction, Intestinal adaptation, Short bowel syndrome, Small bowel transplantation, Trophic factor",
author = "DiBaise, {John K.}",
year = "2014",
month = "3",
doi = "10.1097/MOG.0000000000000035",
language = "English (US)",
volume = "30",
pages = "128--133",
journal = "Current Opinion in Gastroenterology",
issn = "0267-1379",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Short bowel syndrome and small bowel transplantation

AU - DiBaise, John K.

PY - 2014/3

Y1 - 2014/3

N2 - PURPOSE OF REVIEW: The purpose of this review is to provide an update of recent advances in the areas of short bowel syndrome (SBS) and small bowel transplantation (SBT). RECENT FINDINGS: Recent reports from two of the largest multicenter randomized, controlled trials in patients with SBS support the safety and efficacy of teduglutide as an aid to parenteral nutrition weaning. In well selected SBS patients, outcomes as diverse as survival, macronutrient absorption and parenteral nutrition weaning are improved after autologous gastrointestinal reconstructive surgery. SBT is no longer considered investigational and given improved outcomes noted in recent reports, indications for transplantation are expanding. Although SBT early survival rates are approaching those of other organ allografts, long-term graft survival remains suboptimal. SUMMARY: Recently available trophic factors hold promise as aids in restoring freedom from parenteral nutrition support; however, their long-term benefits, preferred timing of administration in relation to the onset of SBS, optimal patient selection for use, duration of treatment and cost effectiveness require further study. Despite recent evidence of improved early survival after SBT, more dedicated research is needed to design more effective strategies to better tolerize small bowel grafts, prevent rejection and, ultimately, improve long-term outcomes. Reserved for well selected patients, autologous gastrointestinal reconstruction should be considered complementary and not antagonistic to SBT.

AB - PURPOSE OF REVIEW: The purpose of this review is to provide an update of recent advances in the areas of short bowel syndrome (SBS) and small bowel transplantation (SBT). RECENT FINDINGS: Recent reports from two of the largest multicenter randomized, controlled trials in patients with SBS support the safety and efficacy of teduglutide as an aid to parenteral nutrition weaning. In well selected SBS patients, outcomes as diverse as survival, macronutrient absorption and parenteral nutrition weaning are improved after autologous gastrointestinal reconstructive surgery. SBT is no longer considered investigational and given improved outcomes noted in recent reports, indications for transplantation are expanding. Although SBT early survival rates are approaching those of other organ allografts, long-term graft survival remains suboptimal. SUMMARY: Recently available trophic factors hold promise as aids in restoring freedom from parenteral nutrition support; however, their long-term benefits, preferred timing of administration in relation to the onset of SBS, optimal patient selection for use, duration of treatment and cost effectiveness require further study. Despite recent evidence of improved early survival after SBT, more dedicated research is needed to design more effective strategies to better tolerize small bowel grafts, prevent rejection and, ultimately, improve long-term outcomes. Reserved for well selected patients, autologous gastrointestinal reconstruction should be considered complementary and not antagonistic to SBT.

KW - Autologous gastrointestinal reconstruction

KW - Intestinal adaptation

KW - Short bowel syndrome

KW - Small bowel transplantation

KW - Trophic factor

UR - http://www.scopus.com/inward/record.url?scp=84894047449&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894047449&partnerID=8YFLogxK

U2 - 10.1097/MOG.0000000000000035

DO - 10.1097/MOG.0000000000000035

M3 - Article

C2 - 24445328

AN - SCOPUS:84894047449

VL - 30

SP - 128

EP - 133

JO - Current Opinion in Gastroenterology

JF - Current Opinion in Gastroenterology

SN - 0267-1379

IS - 2

ER -